THE life SCIENCE
Trusted medical news for healthcare professionals
Monday, 30 March 2026

Highlights

Newsletter
Sign up for one of our newsletters and stay ahead in Life Science
I have read and understood the Privacy Notice and would like to register on the site. *
I consent to receive promotional and marketing emails from The Life Science Feed. To find out how we process your personal information please see our Privacy Notice.
* Indicates mandatory field
News
Nephrology|Urine Microscopy: A Practical Guide to When It Still MattersDermatology|A Systemic Approach to Atopic Dermatitis Treatment SelectionOtolaryngology|Dizziness Resolved with Chronic Rhinosinusitis Treatment: A Physical Therapy CaseRheumatology|Predicting Treatment Response in Psoriatic Arthritis: A New Clinical ModelMusculoskeletal|Sciatica Quality of Life: Saudi-Specific Determinants?Immunology|JC Virus Reactivation as a Diagnostic Clue in DOCK8 DeficiencyOtolaryngology|Dizziness Relief With Sinus Treatment: How Common Is It?Critical Care|When to Doubt the Canadian Head CT RuleEndocrinology|What Still Eludes Us in MASH Research?Immunology|Improving Pediatric Drug Hypersensitivity DiagnosisEndocrinology|Lorlatinib and Diabetic Ketoacidosis An Emerging Class Effect?Endocrinology|Lorlatinib and the Enigma of Autoantibody-Negative DiabetesNephrology|Urine Microscopy: A Practical Guide to When It Still MattersDermatology|A Systemic Approach to Atopic Dermatitis Treatment SelectionOtolaryngology|Dizziness Resolved with Chronic Rhinosinusitis Treatment: A Physical Therapy CaseRheumatology|Predicting Treatment Response in Psoriatic Arthritis: A New Clinical ModelMusculoskeletal|Sciatica Quality of Life: Saudi-Specific Determinants?Immunology|JC Virus Reactivation as a Diagnostic Clue in DOCK8 DeficiencyOtolaryngology|Dizziness Relief With Sinus Treatment: How Common Is It?Critical Care|When to Doubt the Canadian Head CT RuleEndocrinology|What Still Eludes Us in MASH Research?Immunology|Improving Pediatric Drug Hypersensitivity DiagnosisEndocrinology|Lorlatinib and Diabetic Ketoacidosis An Emerging Class Effect?Endocrinology|Lorlatinib and the Enigma of Autoantibody-Negative Diabetes